Crown Bioscience

NOVEMBER 22, 2024

Designed for high-throughput applications, HCI accelerates therapeutic compound screening while uncovering mechanisms of resistance and drug responses.

Compound Screening 52

Compound Screening Research Drugs 52

The ChEMBL-og

APRIL 16, 2024

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g. FDA. This data is currently available for European Medicines Agency drugs only.

Clinical Trials 108

Clinical Trials FDA Cell Based Assays Compound Screening 108

Sygnature Discovery

JANUARY 17, 2023

Sygnature Discovery (“Sygnature”) is delighted to announce the acquisition of SB Drug Discovery, a world leading provider of ion channel and receptor drug discovery research delivering cell line generation and compound screening solutions in neuroscience and other therapeutic indications.

Compound Screening 52

Compound Screening Marketing Assay Development Drugs 52

Sygnature Discovery

SEPTEMBER 11, 2024

Compound Screening Fragment Based Drug Discovery supported by Crystallography or SPR & MST. Covalent compound binding by mass spectrometry. Protein Characterisation & Quality Control Mass spectrometry – intact protein, peptide mapping and native. NMR, FIDA, ITC, SEC-MALS and FSEC.

Science 52

Science Compound Screening Protein Expression RNA 52

Drug Target Review

NOVEMBER 1, 2023

Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. 2013) 56, 2059-2073.

Fragment Screening 96

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96

Sygnature Discovery

SEPTEMBER 5, 2024

Accelerate the entire drug discovery process with increased accuracy and tracking with our state-of-the-art compound management facility. Compound management is central to the drug discovery workflow, encompassing the logistics, storage, tracking, dispensing, and preparation of compounds for testing and analysis.

Compound Screening 52

Compound Screening Production Drugs 52

The Pharma Data

JANUARY 6, 2021

Next-generation digital technologies are having an immense impact on the drug discovery process. The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab.

Cell Based Assays 52

Cell Based Assays Compound Screening Organic Chemistry DNA 52